skip to main menu

hans biomed

  • CEO
  • 우리회사는
    • 국내 1호 조직은행 설립
    • 아시아 최초 FDA 등록
    • 세계일류상품 인증기업
    • 국내 최대 조직공학 연구소 보유
    • 업계최초 코스닥 상장
  • 성장연혁
  • Vision 2022
  • 사업영역
    • Allograft Tissue
    • Silicone Polymer
    • Medical Device
    • Bio Technology
  • 인증현황
  • 글로벌 네트워크
  • 찾아오시는길

HomeHans BiomedOur Company

The first KOSDAQ-listed company in the industry

In October 2009, Hans Biomed Corp. was the first in the field to receive an award from KOSDAQ.

The aim of Hans Biomed Corp. is to compete with the world’s market, rather than staying within Korea, to secure excellent workers and stable investments to upgrade the capacity of our company in order to grow as a global business.

The skin and bone transplant products, which were the first to be developed in Korea, have been acknowledged for their excellent technology and safety, and are gradually replacing the imported products in Korea. In addition, the products are being exported to U.S.A, Europe, South America, Asia and Middle Eastern regions.

In October 2009, Hans Biomed Corp. was the first in the field to receive an award from KOSDAQ.